128 Results

People

  1. Kris
    Kris
  2. Miller
    Miller
  3. Gralla
    Gralla
  4. Heelan
    Heelan
  5. Tyson
    Tyson
  6. Pisters
    Pisters
  7. Rigas
    Rigas
  8. Rusch
    Rusch
  9. Krug
    Krug
  10. Grant
    Grant

Groups

  1. Department of Medicine (128)
  2. Solid Tumor Oncology Division (128)
  3. Thoracic Oncology (128)
  4. Nursing (35)
  5. Surgery (21)
  6. GSK Faculty (20)
  7. Epidemiology and Biostatistics (18)
  8. Biostatistics Service (17)
  9. Survivorship Research (17)
  10. Center for Pancreatic Cancer Research (16)
  1. "female"
  2. "Mark Kris"
Formats
  1. Journal Article (123)
  2. Conference Paper (5)
Groups
  1. Department of Medicine (128)
  2. Solid Tumor Oncology Division (128)
  3. Thoracic Oncology (128)
  4. Nursing (35)
  5. Surgery (21)
  6. GSK Faculty (20)

More Groups

People
  1. Mark Kris (128)
  2. Vincent Miller (32)
  3. Richard Gralla (28)
  4. Robert Heelan (26)
  5. Leslie Tyson (23)
  6. Katherine Pisters (20)

More People

Years
  1. 2023 (2)
  2. 2022 (2)
  3. 2021 (1)
  4. 2020 (2)
  5. 2019 (3)
  6. 2018 (3)

More Years

Publications
  1. Cancer (19)
  2. Journal of Clinical Oncology (14)
  3. Clinical Cancer Research (13)
  4. American Journal of Clinical Oncology (10)
  5. Annals of Thoracic Surgery (6)
  6. JNCI: Journal of the National Cancer Institute (5)

More Publications

Publishers
  1. Wiley Blackwell (21)
  2. American Association for Cancer Research (16)
  3. American Society of Clinical Oncology (16)
  4. Elsevier Inc. (12)
  5. Lippincott Williams & Wilkins (11)
  6. Oxford University Press (11)

More Publishers

Results (128)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study
    Journal Article

    Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non–small cell lung cancer
    Conference Paper

    Lengel, H. B.; Zheng, J.; Tan, K. S.; Liu, C. C.; Park, B. J.; Rocco, G.; Adusumilli, P. S.; Molena, D.; Yu, H. A.; Riely, G. J.; more...
    Mosby Elsevier (2023)

    Fulltext@MSK | Save
  • Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas
    Journal Article

    Paik, P. K.; Luo, J.; Ai, N.; Kim, R.; Ahn, L.; Biswas, A.; Coker, C.; Ma, W.; Wong, P.; Buonocore, D. J.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Deciphering radiological stable disease to immune checkpoint inhibitors
    Journal Article

    Luo, J.; Wu, S.; Rizvi, H.; Zhang, Q.; Egger, J. V.; Osorio, J. C.; Schoenfeld, A. J.; Plodkowski, A. J.; Ginsberg, M. S.; Callahan, M. K.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: A retrospective study
    Journal Article

    Zauderer, M. G.; Martin, A.; Egger, J.; Rizvi, H.; Offin, M.; Rimner, A.; Adusumilli, P. S.; Rusch, V. W.; Kris, M. G.; Sauter, J. L.; more...
    The Lancet Digital Health (2021)

    Fulltext@MSK | Save
  • Clinical outcomes, local–regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab
    Journal Article

    Offin, M.; Shaverdian, N.; Rimner, A.; Lobaugh, S.; Shepherd, A. F.; Simone, C. B. 2nd; Gelblum, D. Y.; Wu, A. J.; Lee, N.; Kris, M. G.; more...
    Radiotherapy and Oncology (2020)

    Fulltext@MSK | Save
  • Novel germline mutations in DNA damage repair in patients with malignant pleural mesotheliomas
    Journal Article

    Guo, R.; DuBoff, M.; Jayakumaran, G.; Kris, M. G.; Ladanyi, M.; Robson, M. E.; Mandelker, D.; Zauderer, M. G.
    Journal of Thoracic Oncology (2020)

    Fulltext@MSK | Save
  • Response to selective RET inhibition with LOXO-292 in a patient with RET fusion-positive lung cancer with leptomeningeal metastases
    Journal Article

    Guo, R.; Schreyer, M.; Chang, J. C.; Rothenberg, S. M.; Henry, D.; Cotzia, P.; Kris, M. G.; Rekhtman, N.; Young, R. J.; Hyman, D. M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Creating a synthetic clinical trial: Comparative effectiveness analyses using an electronic medical record
    Journal Article

    Zauderer, M. G.; Grigorenko, A.; May, P.; Kastango, N.; Wagner, I.; Caroline, A.; Kris, M. G.
    JCO Clinical Cancer Informatics (2019)

    Fulltext@MSK | Save
  • Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers
    Journal Article

    Offin, M.; Feldman, D.; Ni, A.; Myers, M. L.; Lai, W. V.; Pentsova, E.; Boire, A.; Daras, M.; Jordan, E. J.; Solit, D. B.; more...
    Cancer (2019)

    Fulltext@MSK | Save